Empower Clinics Inc., - CEO, Steven McAuley
CEO, Steven McAuley
Source: YouTube (Proactive)
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Empower Clinics (CSE:CBDT) has reported a record number of patient visits at its corporate clinics
  • The company has cited the COVID-19 outbreak as a primary reason for the increase in patient appointments
  • As a medical service provider, Empower’s corporate medical clinics are exempt from certain mandated closures
  • Empower Clinics (CBDT) is up 59.15 per cent to 3 cents per share

Cannabis company Empower Clinics (CSE:CBDT) has reported a record-breaking number of patient visits at its corporate medical clinics. 

The company has cited ongoing COVID-19 impacts as the reason for the unprecedented increase in patient appointments.

As widespread fear sets in over the virus’ toll, Empower visitors have demonstrated a heightened need for CBD medicines.

In addition to experiencing record-pace visits, the company has also made changes to clinic operations and patient management.

In order to effectively weather the COVID-19 storm, Empower has based its changes on recent recommendations from the CDC. The Centers for Disease Control and Prevention has released specific guidance for healthcare facilities, which the company intends to follow.

Empower’s Chairman and CEO, Steven McAuley, commented on the outbreak’s effect on the company and customers. 

“Patients are showing how important their medical cannabis treatment options are to manage increased levels of anxiety, stress, chronic pain, and PTSD.

“We had to quickly adapt clinic operating procedures to ensure optimum safety for employees and patients. We also updated cleaning and sanitation protocols, and provided extensive new communications to our team and patients,” Steven said.

Many US states, including Arizona and Oregon, have declared a State of Emergency, enforcing closures of all non-essential businesses.

However, Empower’s corporate medical clinics are medical service providers, and are therefore considered essential. As a result, the company is not subject to certain mandated closures during the outbreak.

Worldwide, many companies across many industries have seen their share prices plummet due to COVID-19’s impact on the economy.

In contrast, Empower Clinics (CBDT) is up 59.15 per cent to 3 cents per share at 10:38am EST.

More From The Market Herald

" The Market Herald’s Weekly Cannabis Report

Weekly Update – Top Cannabis News Stories

" BioHarvest Sciences welcomes Gavriel Lambert to the Board of Advisors

BioHarvest Sciences (BHSC) has appointed Gavriel Lambert to serve on its Board of Advisors.
Pure Extracts Technologies - CEO, Ben Nikolaevsky.

" Pure Extracts (CSE:PULL) signs supplier agreement with Shoppers Drug Mart

Pure Extracts (PULL) has signed a cannabis supplier agreement with Shoppers Drug Mart.

" Tilray (TSX:TLRY) expands medical cannabis products in the UK

Tilray Brands’ (TLRY) medical cannabis division, Tilray Medical, has expanded its medical cannabis offerings in the United Kingdom.